Show simple item record

dc.contributor.advisorStehno-Bittel, Lisa Aen_US
dc.contributor.authorGagnon, Kendra
dc.date.accessioned2010-03-18T03:47:12Z
dc.date.available2010-03-18T03:47:12Z
dc.date.issued2009-08-18en_US
dc.date.submitted2009en_US
dc.identifier.otherhttp://dissertations.umi.com/ku:10541en_US
dc.identifier.urihttp://hdl.handle.net/1808/5944en_US
dc.description.abstractThere are few reliable and valid methods available for clinicians to assess the functional neurological status of the preterm infant. In this study, we set out to determine whether the Premie-Neuro, a new standardized clinical neurological assessment for preterm infants, is a reliable, valid, and predictive tool. Thirty-four preterm infants were assessed twice, no more than 72 hours apart, using the Premie-Neuro. One assessment per infant was observed and scored by a second examiner. Infants continued to be administered the Premie-Neuro weekly through 37 weeks post-menstrual age or discharge from the neonatal intensive care unit (NICU). At discharge, infants' medical charts were reviewed to determine medical risk factors for neurodevelopmental delay. Follow-up testing was conducted at term adjusted age using the NeoNeuro and at 3 months adjusted age using the Infanib and Alberta Infant Motor Scale. Data were analyzed to determine interrater and test-retest reliabilities, construct validity, and predictive validity of the Premie-Neuro. Premie-Neuro raw scores--particularly those obtained close to NICU discharge--were reliable, valid, and predictive of performance at term and 3 months adjusted age. Premie-Neuro classifications (abnormal, questionable, or normal) based on the Premie-Neuro authors' recommended raw score cut-points were generally not reliable, valid, or predictive. After 34 weeks post-menstrual age (PMA), using a discharge Premie-Neuro raw score cut-point of 99 may be considered low-risk. Infants with scores ranging from 90-99 should be closely monitored to ensure that neurological abnormalities do not emerge. Using these criteria, the Premie-Neuro may be used to identify at-risk babies who will benefit from specialized services and/or close post-term follow-up. This has potential to improve effectiveness, efficiency, and outcomes of early supports and services provided to preterm babies.
dc.format.extent166 pagesen_US
dc.language.isoen_USen_US
dc.publisherUniversity of Kansasen_US
dc.rightsThis item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author.en_US
dc.subjectHealth sciences
dc.subjectRehabilitation and therapy
dc.subjectNeonatal intensive care unit
dc.subjectNeonatology
dc.subjectPremature birth
dc.subjectPrematurity
dc.subjectPremie-neuro
dc.titleReliability and validity of the Premie-Neuro in detecting early neurodevelopmental delay and disability in preterm infants
dc.typeDissertationen_US
dc.contributor.cmtememberGajewski, Byron J
dc.contributor.cmtememberPohl, Patricia S
dc.contributor.cmtememberRadel, Jeff D
dc.contributor.cmtememberWeatherstone, Kathleen B
dc.thesis.degreeDisciplinePhysical Therapy & Rehabilitation Sciences
dc.thesis.degreeLevelPh.D.
kusw.oastatusna
kusw.oapolicyThis item does not meet KU Open Access policy criteria.
kusw.bibid7078659
dc.rights.accessrightsopenAccessen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record